-
Research ethics: Not applicable.
-
Informed consent: Not applicable.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: The authors state no conflict of interest.
-
Research funding: None declared.
References
1. Favresse, J, Delanghe, J. High-resolution capillary electrophoresis for the determination of carbamylated albumin. Clin Chem Lab Med 2022;60:229–34. https://doi.org/10.1515/cclm-2021-0926.Search in Google Scholar PubMed
2. Wauthier, L, Jacques, S, Delanghe, J, Favresse, J. Optimizing the screening of alpha-1 antitrypsin deficiency using serum protein electrophoresis. Clin Chem Lab Med 2023;61:427–34. https://doi.org/10.1515/cclm-2022-0967.Search in Google Scholar PubMed
3. Kumar, S, Paiva, B, Anderson, KC, Durie, B, Landgren, O, Moreau, P, et al.. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol 2016;17:e328–46. https://doi.org/10.1016/s1470-2045(16)30206-6.Search in Google Scholar PubMed
4. Kyle, RA, Gertz, MA, Witzig, TE, Lust, JA, Lacy, MQ, Dispenzieri, A, et al.. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003;78:21–33. https://doi.org/10.4065/78.1.21.Search in Google Scholar PubMed
5. Katzmann, JA, Kyle, RA, Benson, J, Larson, DR, Snyder, MR, Lust, JA, et al.. Screening panels for detection of monoclonal gammopathies. Clin Chem 2009;55:1517–22. https://doi.org/10.1373/clinchem.2009.126664.Search in Google Scholar PubMed PubMed Central
6. Cárdenas, MC, García-Sanz, R, Puig, N, Pérez-Surribas, D, Flores-Montero, J, Ortiz-Espejo, M, et al.. Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part II: methodological and clinical recommendations for the diagnosis and follow-up of monoclonal gammopathies. Clin Chem Lab Med 2023;61:2115–30. https://doi.org/10.1515/cclm-2023-0325.Search in Google Scholar
7. Turner, KA, Frinack, JL, Ettore, MW, Tate, JR, Graziani, MS, Jacobs, JFM, et al.. An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part I: factors impacting limit of quantitation of serum protein electrophoresis. Clin Chem Lab Med 2020;58:533–46. https://doi.org/10.1515/cclm-2019-1104.Search in Google Scholar PubMed
8. Rajkumar, SV, Kyle, RA, Therneau, TM, Melton, LJ3rd, Bradwell, AR, Clark, RJ, et al.. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 2005;106:812–7. https://doi.org/10.1182/blood-2005-03-1038.Search in Google Scholar PubMed PubMed Central
9. Tate, JR, Keren, DF, Mollee, P. A global call to arms for clinical laboratories – harmonised quantification and reporting of monoclonal proteins. Clin Biochem 2018;51:4–9. https://doi.org/10.1016/j.clinbiochem.2017.11.009.Search in Google Scholar PubMed
10. Schild, C, Wermuth, B, Trapp-Chiappini, D, Egger, F, Nuoffer, JM. Reliability of M protein quantification: comparison of two peak integration methods on Capillarys 2. Clin Chem Lab Med 2008;46:876–7. https://doi.org/10.1515/cclm.2008.146.Search in Google Scholar
11. Genzen, JR, Murray, DL, Abel, G, Meng, QH, Baltaro, RJ, Rhoads, DD, et al.. Screening and diagnosis of monoclonal gammopathies: an international survey of laboratory practice. Arch Pathol Lab Med 2018;142:507–15. https://doi.org/10.5858/arpa.2017-0128-cp.Search in Google Scholar
12. Katzmann, JA, Keren, DF. Strategy for detecting and following monoclonal gammopathies. Man Mol Clin Lab Immunol 2016:112–24. https://doi.org/10.1128/9781555818722.ch11.Search in Google Scholar
13. Booth, RA, McCudden, CR, Balion, CM, Blasutig, IM, Bouhtiauy, I, Rodriguez-Capote, K, et al.. Candidate recommendations for protein electrophoresis reporting from the Canadian Society of Clinical chemists monoclonal gammopathy working group. Clin Biochem 2018;51:10–20. https://doi.org/10.1016/j.clinbiochem.2017.10.013.Search in Google Scholar PubMed
14. Dejoie, T, Lakomy, D, Caillon, H, Pegourie, B, Decaux, O. IFM (Intergroupe francophone du myelome) recommendations for uniform interpretation of serum and urine protein electrophoresis in multiple myeloma diagnosis and follow-up. Ann Biol Clin 2016;74:429–41. https://doi.org/10.1684/abc.2016.1166.Search in Google Scholar PubMed
15. Murray, DL, Puig, N, Kristinsson, S, Usmani, SZ, Dispenzieri, A, Bianchi, G, et al.. Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report. Blood Cancer J 2021;11:24. https://doi.org/10.1038/s41408-021-00408-4.Search in Google Scholar PubMed PubMed Central
© 2023 Walter de Gruyter GmbH, Berlin/Boston
